The molecular mechanisms that regulate the balance between proliferation and differentiation of precursors at the onset of hematopoiesis specification are poorly understood. Using a global gene expression profiling approach during the course of embryonic stem cell differentiation, we identified Sox7 as a potential candidate gene involved in the regulation of blood lineage formation from the mesoderm germ layer. In the present study, we show that Sox7 is transiently expressed in mesodermal precursors as they undergo specification to the hematopoietic program. Sox7 knockdown in vitro significantly decreases the formation of both primitive erythroid and definitive hematopoietic progenitors as well as endothelial progenitors. In contrast, Sox7-sustained expression in the earliest committed hematopoietic precursors promotes the maintenance of their multi-potent and self-renewing status. Removal of this differentiation block driven by Sox7-enforced expression leads to the efficient differentiation of hematopoietic progenitors to all erythroid and myeloid lineages. This study identifies Sox7 as a novel and important player in the molecular regulation of the first committed blood precursors.
Introduction
During embryogenesis, the hematopoietic system develops from mesodermal precursors at specific time and locations. The first mesodermal precursors harboring hematopoietic potential, the hemangioblasts, express the VEGF receptor 2 (Flk1) and
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From were initially characterized in vitro upon the differentiation of embryonic stem (ES) cells 1, 2 . Subsequently, these precursors have been identified in vivo in mouse embryo soon after gastrulation 3 and in zebrafish 4 . Hemangioblast precursors are not fully committed to the blood program as they also give rise to endothelium and smooth muscle 1, 5 . The emergence of fully restricted hematopoietic precursors, marked by αIIb-integrin (CD41) expression [6] [7] [8] , occurs soon after the migration of the first hemangioblast to the extraembryonic region 9 . These first blood precursors have a restricted potential and give rise only to primitive erythrocyte or macrophage colonies. Definitive precursors including all myeloid lineages and definitive erythrocytes are detected at the early somites stage, first in the yolk sac at E8.25, then in the embryo proper at E9.0.
The molecular mechanisms that regulate hematopoiesis specification during embryonic development have been investigated in vivo but also in vitro, using the differentiation of ES cells as a model system 10 . The transcription factors Scl and Runx1 play a central role in the specification of hematopoietic precursors, deficiency in either one of these genes leads to early embryonic lethality. Scl -/-embryos lack all hematopoietic lineages 11 and hemangioblasts derived from Scl -/-ES cells are unable to generate hematopoietic precursors 12, 13 . Runx1 deficiency results in the absence of definitive hematopoiesis, sparing only primitive erythrocytes 14, 15 . In vitro experiments using Runx1 -/-ES cells have shown a profound defect in the development of hemangioblast precursors 16 . Other factors such as Fli1, Gata1 or Gata2 were also shown to be part of the molecular network regulating the specification of hematopoietic precursors [17] [18] [19] [20] . However, very little is known about the mechanisms that regulate the expansion and homeostasis of these precursors at the onset of specification. Several
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Most members of the Sox family of transcription factors have been implicated in developmental processes ranging from chondrogenesis for Sox9 to sex determination for Sry, the founding member of this family containing 20 genes in mammals 23 . Sox genes belong to the HMG (High Mobility Group) superfamily and are highly conserved throughout evolution. and 17 are important respectively for primitive and definitive endoderm specification 30, 31 . Sox7 and Sox18 are involved in cardiogenesis and angiogenesis, playing redundant role in both of these processes [32] [33] [34] [35] . Sox17, the only member of this subgroup implicated in hematopoiesis, regulates the maintenance of fetal and neonatal hematopoietic stem cells 36 . To date no role has been assigned for Sox7 in hematopoiesis.
In the present study, we identify Sox7 as a gene specifically expressed in Flk1 + mesodermal precursors. We investigate its potential role in hematopoiesis using the in vitro differentiation of ES cells as a model system, as well as embryos at the onset of
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From hematopoietic development. We show that Sox7 expression is up-regulated in Flk1 + mesodermal precursors then progressively down-regulated as differentiation progresses toward mature blood precursors for primitive and definitive lineages. Knockdown of Sox7 expression using shRNA results in a significant decrease in the formation of hematopoietic progenitors. Using a Tet-on doxycycline inducible expression system, we show that enforced expression of Sox7 in hematopoietic precursors prevents their differentiation to mature primitive and definitive lineages while maintaining their selfrenewal potential. Our study identify Sox7 as a novel player in the molecular regulation of the first committed blood precursors.
Material and Methods

ES cell growth and differentiation
ES cells growth and EB differentiation were performed as previously described 37 . The generation of hemangioblast-derived blast cell colonies and hematopoietic precursors in clonogenic assays were performed in semi-solid hemangioblast and hematopoietic mix respectively. For liquid culture, an equivalent volume of IMDM replaced the methylcellulose. Definitive colonies represent all definitive colonies including macrophages colonies, macrophages/erythrocytes colonies, granulo-macrophages colonies and mix granulo-macrophage-erythroid colonies. All colonies scoring data are
shown from a representative experiment as the mean number of colonies from 3 dishes.
Bars, where visible, represent standard error of the mean.
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Gene Expression Analysis
Total RNA was extracted with an RNeasy kit, treated with RNAse-free DNase (Qiagen) and reverse-transcribed into cDNA with random hexamer using an Omniscript RT kit (Qiagen). PCR reactions were performed using Go Taq (Bioline) and 0.4 μM of each gene specific oligonucleotides primer; sequences are available upon request. Real-time PCR were performed on an ABI 7900 system (Applied Biosystems) using the Exiqon universal probe library and primer designer (Roche). All expression data were calculated relative to β-actin as 2 -Δct . Data are presented as ΔCt values from triplicates normalized to β-actin.
Flow Cytometry
EBs or embryos were trypsinized (TryplE, Gibco) for 3 min and the single cell suspension was analyzed for GFP expression or further stained. Cells were blocked with FcRγII/III antibody (24G2 supernatant) prior to staining with various combinations of Flk1-bio, CD41-PE, CD34-bio, Ter119-PE, cKit-APC, CD71-bio, (PharMingen), CD11b-PE, Tie2-bio, VE-cadherin-647 (eBioscience) followed by strep-Cy7 or strepCy5 (PharMingen). Cells were analyzed on a FacsCalibur flow cytometer or sorted on a Facs Aria (Becton Dickinson). BrdU incorporation (BrdU Flow kit, BD Pharmingen) and Annexin V staining (PE Annexin V apoptosis detection kit I, BD Pharmingen) were performed according to manufacturer's instructions.
Bacterial artificial chromosome transgene cloning
Bacterial artificial chromosome (ID: 250F17) was purchased from mouse bMQ BAC library (Wellcome Trust Sanger Institute, UK). All recombineering steps were performed as previously described 38 . Briefly, we replaced Sox7 exon 1 at the ATG start of 
ShRNA and lentivirus production and transduction
Non-silencing and Sox7 shRNA were purchased from Open Biosystems and expressed in a modified version of the pGIPZ with an Ef1 promoter replacing the CMV promoter.
VSVg pseudotyped lentiviral vectors were produced using the third generation selfinactivating vector system as described 40 . Briefly, viral supernatant was harvested from Sorted mesodermal precursors were transduced at a MOI of 20 in EB media and plated in ultra-low attachment dishes (Corning). After 2 days, aggregates were analyzed as previously described 41 .
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Differences between the control and experimental conditions were compared using a ttest. Statistical significance was considered when P-value was <0.05. Figure S1 ). After 2 days in culture, the transduced cells were tested for hematopoietic potential in clonogenic replating assay ( Figure 1D ). While the control shRNA had a slight non-significant impact on the number of hematopoietic precursors formed, decreasing Sox7 expression using 3 independent shRNA constructs significantly reduced the total number of both primitive and definitive colonies generated. Notably, we observed a correlation between the level of Sox7 knock-down and the decrease in hematopoietic progenitor formation (Supplemental Figure S1C and Figure 1D ). Both Sox7a and Sox7c shRNA efficiently down-regulated Sox7 expression and resulted in low blood progenitor formation. In contrast, Sox7b shRNA was less efficient at down-regulating Sox7 expression and led to a less drastic reduction of hematopoietic progenitors. The potential to generate endothelial colonies was also assayed for the Sox7 knock-down mesodermal precursors in clonogenic replating ( Figure 1E ). Similar to the hematopoietic potential, we observed a
Results
Sox7 is transiently expressed at the onset of hematopoietic specification
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From strong reduction in the ability to form endothelial colonies when Sox7 expression was knock-down. To investigate the underlying basis for the important decrease in both potentials, we analyzed the survival and proliferative status of the mesodermal precursors transduced with lentivirus-expressing shRNA. After two days of culture, the number of cells recovered from Sox7 shRNA cultures was on average 6.4 times lower than from the control shRNA cultures ( Figure 1F ). Furthermore, we also observed a higher frequency of cells undergoing apoptosis as shown by increased Annexin V and 7AAD staining ( Figure 1G , Table S1 ).
Taken together, these data indicate that Sox7 expression is transiently up- 
Sox7-enforced expression blocks hematopoietic differentiation
To further investigate the role of Sox7 at the onset of hematopoietic specification and define the significance of its down-regulation upon differentiation, we analyzed the effect of Sox7 sustained expression in hematopoietic precursors. Using a doxycycline inducible system previously described 21 , we established ES cell clones carrying a Sox7-2A-GFP cDNA (referred to as iSox7). In the presence of doxycycline, iSox7 ES cells were induced to express in bicistronic mode Sox7 and GFP proteins via the efficient internal cleavage of the 2A peptidic sequence 43 , allowing to track Sox7 expressing cells with GFP (Supplemental Figure S3A and S3B). Single cell suspension of iSox7 day 5
EBs which contains primitive and definitive hematopoietic precursors, was replated in clonogenic assay with or without doxycycline to assess the outcome of Sox7-enforced expression on the growth of hematopoietic colonies. In the absence of doxycycline, iSox7 cells gave rise to the expected formation of all colony types, whereas in the presence of doxycycline very few primitive or definitive colonies were detected ( Figure 4A and 4B).
Quite surprisingly however, a large number of colonies, immature in appearance, were observed when Sox7 expression was induced. These colonies were uniformly GFP positive ( Figure 4C ), expressed Scl and Gata1, both indicative of hematopoietic commitment, and Sox7 ( Figure 4D ) with, on average, an 11-fold higher level than the endogenous expression detected at day 1 of hemangioblast differentiation (Supplemental Figure S3C ). Similar results were observed with 3 independent iSox7 ES clones (not shown). Analysis of differentiation markers on pooled colonies indicated that without induction, around 10% of the cells expressed CD11b or Ter119, marking respectively macrophage-granulocyte and erythroid lineages ( Figure 4E ). In contrast, upon Sox7 predominantly to erythrocytes after 6 days and mostly mast cells after 10 days whereas macrophages and megakaryocytes were observed at all stages of the culture ( Figure 6C and data not shown).
To study at a clonal level the potential of these blastic colonies, individual iSox7 + colonies were picked and expanded without doxycycline. After 6 days in liquid culture, most colonies (over 90%) gave rise to erythrocytes, macrophages, neutrophils and megakaryocytes ( Figure 6D ). The clonogenic potential of iSox7 + colonies was next determined in semi-solid replating without doxycycline. Most individually picked colonies contained a high frequency of progenitors developing into single lineage colonies such as primitive erythrocytes or macrophages but also multi-lineages colonies of granulo-macrophages or mixed lineages ( Figure 6E ). As hematopoietic and endothelium lineages can be derived from the same precursor, we also assessed the potential of these colonies to generate endothelium. However, in two independent assays, iSox7 + cells failed to give rise to endothelial cells. Single cell suspension derived from 
Gastrulating embryos contain Sox7-responsive hematopoietic precursors
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Discussion
The data described in the present study identify Sox7 as a novel and important player in the molecular regulation of hematopoietic specification from mesodermal precursors. We show that Sox7 is transiently expressed during the transition from Flk1 Endothelium and blood are two closely related lineages, emerging at the same time and location during early embryogenesis, observation that indeed led almost a century ago to the hypothesis of a common precursor for these two lineages 46 restricts the potential of mesodermal precursors to a hematopoietic fate only, suggesting a possible implication of Sox7 in hematopoietic specification rather than only in proliferation and/or differentiation. The data presented here do not allow us to draw a conclusion about the potential role of Sox7 in hematopoietic specification but it will be extremely interesting in future experiments to address this hypothesis.
Sox17 was recently identified as a critical regulator of the proliferation of fetal and neonatal hematopoietic stem cells 36 however it seems unlikely that Sox7 and Sox17 may simply play redundant functions during embryonic hematopoiesis. Indeed, the first committed hematopoietic precursors expressing significant level of Sox7 are generated around E7.5 of embryonic development in the yolk sac. These progenitors give rise mostly to primitive erythrocytes then definitive precursors but they are fully devoid of any hematopoietic stem cell activity 49 . In contrast, Sox17 appears to be critical for the proliferation of hematopoietic stem cells that start to be generated in the aorta-gonadomesonephros (AGM) region after E10.5 of embryonic development 50 . These two sets of hematopoietic precursors, generated at different time in embryonic development, have very different potential and as such, are not likely to be fully controlled by the same sets of genes. Supporting this notion, we found that in contrast to Sox7, the expression of Sox17 was not up-regulated in the Bry-GFP + Flk1 + population but rather down-regulated relative to Bry-GFP + Flk1 -mesodermal precursors (GL, VK unpublished observation).
Our data demonstrate that the sustained expression of Sox7 is sufficient to completely alter the balance between proliferation and differentiation at the onset of hematopoiesis. However, the removal of Sox7-enforced expression fully restores this equilibrium and leads to the efficient differentiation of hematopoietic progenitors. This For For For 
